ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CAR-T cell update: Therapy improves outcomes for patients with B-cell lymphoma
December 04, 2018In their phase-2 study of tisagenlecleucel (marketed as KYMRIAH®), to be published on-line Dec. 1, 2018 in the New England Journal of Medicine, an international team of researchers evaluated 93 patients with relapsed or refractory diffuse large B-cell lym
Pharma Sources Insight January 2025
